ResMed (RMD) Misses Q3 EPS by 10c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $228.42 +0.07%
Revenue Growth %: +6.9%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: +6.9%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $1.32, $0.10 worse than the analyst estimate of $1.42. Revenue for the quarter came in at $864.5 million versus the consensus estimate of $897.04 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Piper Sandler Reiterates Overweight Rating on Block Inc. (XYZ)
- Cargojet Inc. (CJT:CN) (CGGJF) PT Raised to $128 at TD Cowen, maintains bullish call
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
